By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Sandoz Group AG

Sandoz Group AG (0SAN.L)

LSE Currency in CHF
CHF 50.30
-CHF 0.13
-0.26%
Last Update: 28 Aug 2025, 16:34
CHF 22.13B
Market Cap
0.00
P/E Ratio (TTM)
1.19%
Forward Dividend Yield
CHF 23.50 - CHF 50.70
52 Week Range

0SAN.L Stock Price Chart

Explore Sandoz Group AG interactive price chart. Choose custom timeframes to analyze 0SAN.L price movements and trends.

0SAN.L Company Profile

Discover essential business fundamentals and corporate details for Sandoz Group AG (0SAN.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Pharmaceuticals

IPO Date

10 Oct 2023

Employees

22.05K

CEO

Richard Saynor

Description

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. The company was founded in 1886 and is headquartered in Rotkreuz, Switzerland.

0SAN.L Financial Timeline

Browse a chronological timeline of Sandoz Group AG corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 3 Mar 2026

Earnings released on 7 Aug 2025

EPS came in at CHF 1.16 matching the estimated CHF 1.16, while revenue for the quarter reached CHF 4.15B , meeting expectations.

Dividend declared on 17 Apr 2025

A dividend of CHF 0.60 per share was announced, adjusted to CHF 0.60. The dividend was paid on 23 Apr 2025.

Earnings released on 5 Mar 2025

EPS came in at CHF 1.44 falling short of the estimated CHF 1.48 by -2.70%, while revenue for the quarter reached CHF 4.82B , missing expectations by -0.82%.

Earnings released on 30 Oct 2024

Earnings released on 8 Aug 2024

EPS came in at CHF 0.16 falling short of the estimated CHF 0.90 by -82.59%, while revenue for the quarter reached CHF 2.28B , missing expectations by -48.78%.

Earnings released on 30 Jun 2024

EPS came in at CHF 0.16 , while revenue for the quarter reached CHF 2.27B .

Dividend declared on 3 May 2024

A dividend of CHF 0.45 per share was announced, adjusted to CHF 0.45. The dividend was paid on 7 May 2024.

Earnings released on 31 Dec 2023

EPS came in at -CHF 0.15 , while revenue for the quarter reached CHF 2.12B .

Earnings released on 30 Sept 2023

EPS came in at -CHF 0.17 , while revenue for the quarter reached CHF 2.31B .

Earnings released on 30 Jun 2023

EPS came in at CHF 0.24 , while revenue for the quarter reached CHF 2.21B .

Earnings released on 31 Mar 2023

EPS came in at CHF 0.25 , while revenue for the quarter reached CHF 2.25B .

Earnings released on 31 Dec 2022

EPS came in at CHF 0.41 , while revenue for the quarter reached CHF 2.14B .

Earnings released on 30 Sept 2022

EPS came in at CHF 0.43 , while revenue for the quarter reached CHF 2.28B .

0SAN.L Stock Performance

Access detailed 0SAN.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run